Hubei Goto Biopharm Co.,Ltd. Stock

Equities

300966

CNE100004K94

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-06-04 pm EDT 5-day change 1st Jan Change
17.54 CNY -1.57% Intraday chart for Hubei Goto Biopharm Co.,Ltd. -4.93% -23.64%
Sales 2022 605M 83.43M Sales 2023 566M 78.16M Capitalization 2.65B 365M
Net income 2022 40M 5.52M Net income 2023 23M 3.17M EV / Sales 2022 5.67 x
Net Debt 2022 317M 43.73M Net Debt 2023 604M 83.31M EV / Sales 2023 5.74 x
P/E ratio 2022
77.5 x
P/E ratio 2023
115 x
Employees 631
Yield 2022 *
-
Yield 2023
0.07%
Free-Float 40.55%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.57%
1 week-4.93%
Current month-6.35%
1 month-1.29%
3 months-11.01%
6 months-28.47%
Current year-23.64%
More quotes
1 week
16.92
Extreme 16.92
19.47
1 month
16.92
Extreme 16.92
23.80
Current year
12.03
Extreme 12.03
25.70
1 year
12.03
Extreme 12.03
28.78
3 years
12.03
Extreme 12.03
60.82
5 years
12.03
Extreme 12.03
79.98
10 years
12.03
Extreme 12.03
79.98
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 06-05-14
Director of Finance/CFO 50 16-09-30
Director/Board Member 46 08-07-31
Members of the board TitleAgeSince
Director/Board Member 74 18-10-15
Director/Board Member 54 18-10-15
Chief Executive Officer 53 06-05-14
More insiders
Date Price Change Volume
24-06-04 17.54 -1.57% 3 679 900
24-06-04 17.82 -1.87% 6,071,687
24-06-03 18.16 -3.04% 4,692,034
24-05-31 18.73 -1.21% 4,484,800
24-05-30 18.96 +0.48% 6,847,799

End-of-day quote Shenzhen S.E., June 04, 2024

More quotes
Hubei Goto Biopharm Co Ltd is a China-based company mainly engaged in the research and development, production and sales of steroidal drug raw materials. The Company's main products are starting materials and intermediates required for the production of steroid drugs. The starting materials refer to the products obtained from the conversion of plant sterols through biological fermentation technology. These products are important raw materials for downstream pharmaceutical intermediates and active pharmaceutical ingredient manufacturers and belong to the upstream products in the steroid drug industry chain. The Company's intermediate products mainly include sex hormone intermediates, progesterone intermediates, corticosteroid intermediates and other products.
More about the company
  1. Stock Market
  2. Equities
  3. 300966 Stock